Dr Neil Weir
Non Executive Director
Biotechnology
Ondek
Australia
Biography
Neil is Senior Vice-President, Discovery UCB S.A., responsible for global discovery at UCB, overseeing an integrated portfolio of small molecule and antibody therapeutic projects in the areas of Immunology and Neurology. The discovery team Neil is responsible for has transitioned twenty novel molecules into development, comprising small molecules and antibodies, Neil was one of the inventors of the drug Cimzia®, a novel pegylated anti-TNF. Prior to his role at UCB, Neil was head of Discovery at Celltech R and D in the UK during which time he was involved in the discovery and development of antibody and antibody fragment-based drugs. Neil is a member of the Research Directors Group of EFPIA (The European Federation of Pharmaceutical Industries and Associations) and has sponsored three call topics in the European Innovative Medicines Initiative (IMI). He is a member of the MRC Translational Research Group and the HealthTech and Medicines KTN Steering Board, a member of the MRC’s Stratified Medicine Steering Group and chair of the industry advisory panel for UCL vision course for senior executive training for the BioIndustries.
Research Interest
Immunology and Neurology
